Introduction
Methods
Results
Discussion
Limitations
Conclusion

INTRODUCTION

Seizures are one of the most common neurological disorders in children, with a prevalence of approximately 1%.^1,2 Febrile seizure is the most common type of pediatric seizure.³ In comparison, afebrile seizure is relatively uncommon, but it is clinically significant. Numerous studies have reported a higher risk of abnormal neuroimaging findings and recurrence of seizure.^4-6

Previous studies have recommended electroencephalography (EEG) and/or neuroimaging after the first afebrile seizure.^7-12 However, pediatric seizure patients rarely undergo EEG in the emergency department (ED) due to differences in staffing and problems such as limited EEG lab availability at night.¹³ In contrast, brain imaging tests, including computed tomography and magnetic resonance imaging (MRI), are relatively accessible in the ED. In a previous multicenter study, a majority of the seizure patients (81%) underwent neuroimaging studies in the ED, while EEG was performed in only 3% of the patients at the same time due to lack of testing availability.¹⁴ Furthermore, emergent brain imaging allows clinicians to identify intracranial pathologies and the need for immediate intervention in children with afebrile seizures.^9-12

Clinicians should carefully consider the risks and/or benefits of brain imaging in pediatric patients because they typically require sedation and are much more sensitive to ionizing radiation than adults.^15,16 Therefore, it is important to identify associated factors of neuroimaging abnormalities in pediatric patients with first afebrile seizure. Clinical guidelines for evaluating the first afebrile seizure in children, which were published by the American Academy of Neurology, Child Neurology Society, and American Epilepsy Society, suggest that emergent neuroimaging should be performed in all pediatric patients who present with Todd’s paralysis or have not returned to baseline status within a few hours after the seizure.¹⁷ However, previous studies on emergent neuroimaging in pediatric patients with afebrile seizure did not take lab results into consideration.

The purpose of this study was to identify associated factors of abnormalities on emergent neuroimaging tests after the first afebrile seizure episode in children based on historical findings, physical examination, and lab results.

METHODS

Study Design and Setting

This retrospective, multicenter study recruited pediatric patients who presented to three university hospitals (in Seoul, Chungcheong, and Gyeonggi, Republic of Korea) with seizures between January 2018–December 2020. These EDs serve approximately 40,000, 50,000, and 60,000 patients per year, respectively. Children aged 1 month to 18 years, who were afebrile for at least 24 hours and presented with their first seizure, were enrolled. We excluded children with a known seizure disorder, acute trauma, or incomplete electronic health records (EHR). The study was approved by our hospital institutional review board (IRB file no. 2021-03-030).

Population Health Research Capsule

What do we already know about this issue?

Neuroimaging is recommended in children presenting with a first afebrile seizure in the emergency department. However, there are risks of sedation and radiation.

What was the research question?

What factors are associated with neuroimaging abnormalities in children with a first afebrile seizure?

What was the major finding of the study?

Abnormal neuroimaging findings were present in 29% of patients. Higher levels of lactate and bilirubin, Todd’s paralysis, and the absence of poor oral intake were factors associated with neuroimaging abnormalities.

How does this improve population health?

Our model could help emergency physicians identify pediatric patients who require brain imaging based on laboratory results and clinical findings.

Patient Identification and Data Collection

We reviewed the EHR of 2,009 patients evaluated at the three EDs for seizures between January 2018–December 2020. In our retrospective study, we estimated a sample size based on a previous study about calculating adequate sample size for developing a clinical prediction model.¹⁸ Data was extracted by three experienced reviewers. In case of discrepancy, the data extracted by the most senior reviewer was recorded. The following data was extracted from the medical records: age; gender; symptoms (ie, headache, vomiting, and poor oral intake [POI]); past history (related to birth, neonatal intensive care unit [NICU] admission, and family); number of seizures in the first 24 hours after presentation; duration of seizure; presence of Todd’s paralysis; postictal features; seizure type; physical exam findings (ie, neck stiffness and Babinski sign); laboratory results (ie, blood pH, complete blood cell count, and bicarbonate, lactic acid, blood urea nitrogen, creatinine, glucose, albumin, bilirubin, aspartate aminotransferase, alanine transaminase, and C-reactive protein [CRP] levels). POI was defined as a lack of interest in feeding or a problem receiving the proper amount of nutrition and Todd’s paralysis was defined as a neurological condition, in which a seizure is followed by a brief period of temporary paralysis. Also, lactate level above 2.0 mg/dL and bilirubin level above 1.2 mg/dL were considered abnormal in our laboratory results. Data collection was conducted in accordance with the recommendations of Worster et. al to reduce bias and comply with standards for EHR review.¹⁹

Neuroimaging Studies

Because the three study EDs share the same medical center, a single protocol was followed for all pediatric patients experiencing their first afebrile seizure. Therefore, most of the patients underwent brain imaging tests. We excluded patients for whom brain imaging was performed 24 hours post seizure, characterizing them as having incomplete EHR. A single neuroradiologist reviewed the neuroimaging studies. The neuroimaging findings were classified as cyst (ie, neuroglial or arachnoid cyst), infarction, hemorrhage, mass, encephalitis, dysplasia (ie, developmental venous anomaly or lissencephaly), focal (ie, focal heterotopia or focal encephalomalacia), cortical edema, periventricular leukomalacia [PVL], and non-specific lesions (ie, non-specific, increased T2 signal intensity in periventricular white matter).¹⁰ In brain imaging studies, 157 patients (48.6%) underwent brain CT, 268 patients (83.0%) underwent MRI, and 102 patients (31.6%) underwent both CT and MRI.

Statistical Analysis

We present data as absolute numbers or relative frequencies for categorical variables, and as medians with interquartile ranges for continuous variables. P-values < 0.05 were considered to indicate statistical significance. We used Fisher’s exact test or the chi-squared test to analyze categorical variables and the Mann-Whitney U test to analyze continuous variables. The Shapiro-Wilk test showed that all continuous variables did not follow a normal distribution. Multivariable logistic regression analysis was performed on factors that were statistically significant in the univariable logistic regression analysis and variables reported to be significantly associated in previous studies.^11,12,17 We calculated odds ratios (OR) with 95% confidence intervals (CI) to quantify the associations between the various factors and neuroimaging abnormalities. A nomogram based on the multivariable logistic analysis was constructed to predict brain imaging abnormalities. We performed statistical analyses using SPSS version 26.0 (IBM Corp., Armonk, NY) and R version 4.1.3 (R Foundation for Statistical Computing, Vienna, Austria).

RESULTS

A total of 411,689 patients visited the three EDs during the study period, including 2,009 pediatric patients who visited the EDs due to a seizure. We excluded patients with fever (1,398), history of seizure disorder (186), history of acute trauma (59), and incomplete EHR including absence of neuroimaging tests (43). Finally, 323 patients were enrolled in the study (Figure 1).

General Characteristics

Table 1 shows the baseline characteristics of the patients. The median age was 7 (2.5–11.5) years. In total, 26 patients (8.05%) were admitted to the NICU, and 48 (14.86%) had a familial history of seizures. Headache and POI were present in 33 (10.22%) and 24 (7.43%) patients, respectively. The median number of seizures was 1 (1–1) and the median seizure duration was 3 (2–5) minutes. Twelve patients (3.72%) developed Todd’s paralysis, and 231 (71.52%) developed a postictal state. Most seizures were of the generalized tonic-clonic (GTC) type (277, 85.76%), followed by focal type (43, 13.31%) and secondary GTC type (3, 0.93%).

Comparison of the Two Groups with Normal and Abnormal Neuroimaging

The differences between the normal and abnormal neuroimaging groups are summarized in Table 2. Abnormal neuroimaging findings were present in 95 patients (29.41%). No significant differences were observed in age, gender, medical history, number of seizures, or seizure type between the two groups. On physical examination, the number of patients with neck stiffness was greater in the abnormal neuroimaging group but showed no significant difference (3.16% and 0.44%, respectively; P = 0.08), and Babinski sign was identified in only one case, making it difficult to have a significant difference (1.05% and 0%, respectively; P = 0.29).

Fewer patients in the abnormal neuroimaging group had POI compared to the normal neuroimaging group (2.11% and 9.65%, respectively; P=0.02). In addition, Todd’s paralysis was observed more frequently in the abnormal than normal neuroimaging group (7.37% and 2.19%, respectively; P=0.05). Compared to the normal neuroimaging group, patients in the abnormal neuroimaging group had higher levels of lactic acid (2 and 2.2 milligrams per deciliter [mg/dL], respectively; P=0.02) and bilirubin (0.34 and 0.4 mg/dL, respectively; P=0.03), and lower levels of albumin (4.6 and 4.5 grams/dL, respectively; P=0.02) and CRP (1.3 and 0.7 mg/L, respectively; P=0.03).

Main Outcomes

The results of the univariable and multivariable logistic regression analyses are shown in Table 3. Neck stiffness did not show a significant difference in univariable logistic regression analysis (OR 7.402, 95% CI 0.760–72.087; P=0.09). Todd’s paralysis was significantly associated with abnormal neuroimaging findings (OR 3.718, 95% CI 1.034–13.364; P=0.04). Furthermore, POI was inversely associated with neuroimaging abnormalities (OR 0.213; 95% CI 0.046–0.976; P=0.05). The lactic acid (OR 1.161, 95% CI 1.035–1.302; P=0.01) and bilirubin (OR 3.330, 95% CI 1.114–9.952; P=0.03) levels were significantly associated with abnormal neuroimaging findings.

We used these factors to construct a nomogram (Figure 2) for predicting the probability of abnormal neuroimaging findings. The nomogram showed that lactate was the strongest associated factor of neuroimaging abnormalities, followed by bilirubin, absence of POI, and Todd’s paralysis. Each associated factor was rated on a point scale (0–100). The probability of neuroimaging abnormalities was predicted by summing the scores of all factors. For example, a patient with Todd’s paralysis and a bilirubin level of 1.0 mg/dL would have 45 and 40 points for each factor. After summing the scores, there were 85 total points, and the probability of neuroimaging abnormalities was 0.4 for the patient.

Neuroimaging Studies

In total, 95 patients had abnormal neuroimaging findings, which are summarized in Figure 3. The most common finding was cyst (30, 31.58%), followed by non-specific findings (19, 17.89%), infarction (10, 10.53%), dysplasia (9, 9.47%), and focal lesion (8, 8.42%). Hemorrhage (5, 5.26%), mass (5, 5.26%), PVL (5, 5.26%), encephalitis (3, 3.16%), and cortical edema (3, 3.16%) were also frequently identified.

DISCUSSION

In this multicenter retrospective study, we investigated associated factors of emergent neuroimaging abnormality in children with first-onset, non-febrile seizure from historical findings, physical exam, and lab results. Todd’s paralysis, absence of POI, and higher levels of lactate and bilirubin were significantly associated with the abnormalities of brain imaging tests. In a previous prospective observational study, Paramasivam et al reported that 22 of 65 patients (33.85%) experiencing new-onset afebrile seizures had abnormal neuroimaging findings.²⁰ In addition, Al-Shami et al reported that 32 of 96 pediatric patients (33.33%) with afebrile seizures had neuroimaging abnormalities that were considered to be clinically significant by an experienced neuroradiologist.¹² Similarly, we found that 95 pediatric patients (29.41%) with afebrile seizures had abnormal neuroimaging findings.

Current practice guidelines for the evaluation of children experiencing their first afebrile seizure suggest that manifestations of focal seizures, such as Todd’s paralysis and persistent mental status change, are risk factors for neuroimaging abnormalities.¹⁷ Aprahamian et al reported that Todd’s paralysis and age <18 months were associated factors of neuroimaging abnormalities requiring urgent care.¹¹ Amagasa et al also reported that neurological disorder, including impaired awareness, Todd’s paralysis, and ataxia in physical examinations, was a risk factor for brain imaging abnormalities in children with first afebrile seizure.²¹ In our study, we investigated both Todd’s paralysis and physical findings such as neck stiffness and Babinski sign. We found that Todd’s paralysis was a significant associated factor of neuroimaging abnormalities, while age, neck stiffness, and Babinski sign were not. Whether age is related to neuroimaging abnormalities varies from study to study.^11,20 Similar to our study, Paramasivam et al reported no significant association between age and gender with neuroimaging abnormalities.²⁰ In our study, neck stiffness and Babinski sign showed higher numbers in the abnormal neuroimaging group. However, the number of patients with neck stiffness or Babinski sign was too small to determine the association. Further research on more detailed neurological examinations in pediatric afebrile seizure patients is needed.

In pediatric patients, POI may indicate several metabolic abnormalities such as hypoglycemia, hyponatremia, and hypocalcemia that can cause convulsions.^22,23 According to a previous study, 95.2% of infants and young children with gastroenteritis complained of POI and presented with ketosis or hypoglycemia, as well as hyponatremic dehydration.²⁴ In addition, pediatric patients with certain metabolic disorders, such as glucose transporter type 1 deficiency syndrome, may experience seizures; however, the syndrome is rare with an estimated birth incidence of 1 in 24,300 according to a previous study. For these patients, a ketogenic diet may prevent seizures.^24-26 In our study, absence of POI was an associated factor of neuroimaging abnormalities, where absence of POI may indicate intracranial pathology rather than metabolic problems in children.

With regard to lab results, previous studies reported that the lactic acid level is an excellent biomarker for discriminating seizures from psychogenic episodes and syncope, although the underlying mechanism is unclear.^27,28 Gunawan et al recently reported a correlation between serum lactate level and abnormal brain MRI findings in children with status epilepticus.²⁹ Lactate elevation and adenosine triphosphate depletion during the early phase of seizures are related to hypermetabolic neuronal damage.²⁹ Similarly, lactic acid was a strong associated factor of neuroimaging abnormalities in our pediatric patients experiencing their first afebrile seizure. In addition, Shapiro et al reported that unbound and free unconjugated bilirubin can selectively damage the central nervous system in the developing brain.³⁰ However, bilirubin toxicity to the brain is only applicable to early neonatal age. In our study, a higher level of bilirubin was found to be significantly associated with neuroimaging abnormalities in pediatric patients with first afebrile seizure. Further research on how bilirubin affects the brain in pediatric afebrile seizure patients is needed.

The main strength of our study is that it presents a nomogram based on lab results and clinical findings, such as Todd’s paralysis and POI, to predict neuroimaging abnormalities in children experiencing their first afebrile seizure. Because this data can be easily acquired in the ED, our predictive model could help identify pediatric patients who require brain imaging. To the best of our knowledge, this is the first study to identify associated factors of neuroimaging abnormalities in patients experiencing afebrile seizure based on symptoms and lab findings.

LIMITATIONS

Our study had several limitations. First, selection bias may have occurred due to the retrospective study design. However, the three study EDs shared the same protocol for pediatric afebrile seizure, which would minimize selection bias. While our goal was to investigate all known factors with regard to neuroimaging abnormalities in pediatric afebrile seizure patients, some may have been missed due to the limitations of a retrospective study design.^{17, 20} Second, our neuroimaging findings are unclear as to whether the findings were the cause or the consequence of seizures. Third, caution should be exercised when generalizing the results because of regional differences. However, the study hospitals are located in major population centers in the Republic of Korea (Seoul, Bucheon, and Cheonan), which should improve the generalizability. Finally, while we estimated a sample size considering a previous study, the sample size might be too small to be generalized.¹⁸ To overcome these limitations, large-scale prospective studies on neuroimaging abnormalities in pediatric patients with afebrile seizures are needed.

CONCLUSION

We found that Todd’s paralysis, absence of POI, and higher levels of lactic acid and bilirubin were significant associated factors of neuroimaging abnormalities in pediatric patients with first afebrile seizure. We then constructed a nomogram to aid emergency physicians in making decisions quickly about initiating emergent neuroimaging tests for children with first afebrile seizure, as pediatric seizure patients with these findings should be closely monitored.

Footnotes

Section Editor: Richard Lucarelli, MD

Full text available through open access at http://escholarship.org/uc/uciem_westjem

Address for Correspondence: Sangsoo Han, MD, Soonchunhyang University Bucheon Hospital, Department of Emergency Medicine, 170 Jomaru-ro, Bucheon 14584, Republic of Korea. Email: brayden0819@schmc.ac.kr. 3 / 2023; 24:279 – 286

Submission history: Revision received June 13, 2022; Submitted December 19, 2022; Accepted December 15, 2022

Conflicts of Interest: By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. No author has professional or financial relationships with any companies that are relevant to this study. There are no conflicts of interest or sources of funding to declare.

REFERENCES

1. Tharp BR. An overview of pediatric seizure disorders and epileptic syndromes. Epilepsia. 1987;28:S36-44.

2. Russ SA, Larson K, Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics. 2012;129(2):256-64.

3. Pediatrics AA. Neurodiagnostic evaluation of the child with a simple febrile seizure. Pediatrics. 2011;127(2):389-94.

4. Hsieh D, Chang T, Tsuchida T, et al. New-onset afebrile seizures in infants: role of neuroimaging. Neurology. 2010;74(2):150-6.

5. Berg AT, Levy SR, Novotny EJ, et al. Predictors of intractable epilepsy in childhood: a case-control study. Epilepsia. 1996;37(1):24-30.

6. Berg AT. Risk of recurrence after a first unprovoked seizure. Epilepsia. 2008;49:13-8.

7. Shinnar S, Berg AT, Moshe SL, et al. The risk of seizure recurrence after a first unprovoked afebrile seizure in childhood: an extended follow-up. Pediatrics. 1996;98(2):216-25.

8. Panayiotopoulos C. Significance of the EEG after the first afebrile seizure. Arch Dis Child. 1998;78(6):575-7.

9. Sharma S, Riviello JJ, Harper MB, Baskin MN. The role of emergent neuroimaging in children with new-onset afebrile seizures. Pediatrics. 2003;111(1):1-5.

10. Gaillard WD, Chiron C, Helen Cross J, et al. Guidelines for imaging infants and children with recent-onset epilepsy. Epilepsia. 2009;50(9):2147-53.

11. Aprahamian N, Harper M, Prabhu S, et al. Pediatric first time non-febrile seizure with focal manifestations: Is emergent imaging indicated?. Seizure. 2014;23(9):740-5.

12. Al-Shami R, Khair AM, Elseid M, et al. Neuro-imaging evaluation after the first afebrile seizure in children: a retrospective observational study. Seizure. 2016;43:26-31.

13. Yigit O, Eray O, Mihci E, et al. The utility of EEG in the emergency department. Emerg Med J. 2012;29(4):301-5.

14. Huff JS, Morris DL, Kothari RU, et al. Emergency department management of patients with seizures: a multicenter study. Acad Emerg Med. 2001;8(6):622-8.

15. Children of adults exposed to radiation. Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII, Phase 2. 2006:228-232.

16. Raschle N, Zuk J, Ortiz-Mantilla S, et al. Pediatric neuroimaging in early childhood and infancy: challenges and practical guidelines. Ann N Y Acad Sci. 2012;1252(1):43-50.

17. Hirtz D, Ashwal S, Berg A, et al. Practice parameter: evaluating a first nonfebrile seizure in children: report of the Quality Standards Subcommittee of the American Academy of Neurology, the Child Neurology Society, and the American Epilepsy Society. Neurology. 2018;5:338.

18. Riley RD, Ensor J, Snell KI, et al. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020;368:m411.

19. Worster A, Bledsoe RD, Cleve P, et al. Reassessing the methods of medical record review studies in emergency medicine research. Ann Emerg Med. 2005;45(4):448-451.

20. Paramasivam M, Muthuraja M. Identification and comparing the risk factors of new onset afebrile seizures with neuroimaging studies in children. Int J Contemp Pediatr. 2001;43(3):261-9.

21. Amagasa S, Uematsu S, Tsuji S, et al. Identification of children with first afebrile seizure for whom neuroimaging is unnecessary. Seizure. 2021;93:140-4.

22. Szlam S, Meredith M. Shake, rattle, and roll: an update on pediatric seizures. Pediatr Emerg Care. 2013;29(12):1287-94.

23. Lee J-Y, Ryu J-M, Lee JS, et al. Clinical implications of ketosis in children with benign convulsions with mild gastroenteritis. J Clin Neurol. 2020;16(1):96-101.

24. Zupec-Kania B, Zupanc ML. Long-term management of the ketogenic diet: seizure monitoring, nutrition, and supplementation. Epilepsia. 2008;49:23-6.

25. Luat AF, Coyle L, Kamat D. The ketogenic diet: a practical guide for pediatricians. Pediatr Ann. 2016;45(12):e446-50.

26. Symonds JD, Zuberi SM, Stewart K, et al. Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort. Brain. 2019;142(8):2303-18.

27. Matz O, Zdebik C, Zechbauer S, et al. Lactate as a diagnostic marker in transient loss of consciousness. Seizure. 2016;40:71-5.

28. Magnusson C, Herlitz J, Höglind R, et al. Prehospital lactate levels in blood as a seizure biomarker: a multi-center observational study. Epilepsia. 2021;62(2):408-15.

29. Gunawan PI, Noviandi R, Samosir SM. The correlation between long-lasting serum lactate and brain MRI abnormality in children with status epilepticus. 2022. Available at: https://www.researchsquare.com/article/rs-1136749/v1. Accessed December 16, 2022.

30. Shapiro SM. Bilirubin toxicity in the developing nervous system. Pediatr Neurol. 2003;29(5):410-21.